Passa al contenuto
Merck

An autoinflammatory disease due to homozygous deletion of the IL1RN locus.

The New England journal of medicine (2009-06-06)
Sreelatha Reddy, Shuang Jia, Rhonda Geoffrey, Rachel Lorier, Mariko Suchi, Ulrich Broeckel, Martin J Hessner, James Verbsky
ABSTRACT

We describe a patient with an autoinflammatory disease in which the main clinical features are pustular rash, marked osteopenia, lytic bone lesions, respiratory insufficiency, and thrombosis. Genetic studies revealed a 175-kb homozygous deletion at chromosome 2q13, which encompasses several interleukin-1 family members, including the gene encoding the interleukin-1-receptor antagonist (IL1RN). Mononuclear cells, obtained from the patient and cultured, produced large amounts of inflammatory cytokines, with increasing amounts secreted after stimulation with lipopolysaccharide. A similar increase was not observed in peripheral-blood mononuclear cells from a patient with neonatal-onset multisystem inflammatory disorder (NOMID). Treatment with anakinra completely resolved the symptoms and lesions.